3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Carcinoma, Hepatocellular
8
Nasopharyngeal Carcinoma
6
Esophageal Neoplasms
6
Neoplasm Metastasis
5
Triple Negative Breast Neoplasms
4
Stomach Neoplasms
4
Melanoma
4
Advanced NSCLC
4
Squamous Cell Carcinoma of Head and Neck
3
Recurrence
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Small Cell Lung Carcinoma
2
Sarcoma
2
Neoplasms
2
Lung Neoplasms
2
Locally Advanced Rectal Cancer
2
Leukemia, Myeloid, Acute
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Biliary Tract Neoplasms
2
Advanced Solid Tumors
2
Advanced Solid Tumor
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Radiotherapy
4
pembrolizumab
2
aldesleukin
2
Specimen Handling
2
Radiation
2
Mitomycin
2
Drug Therapy
2
Capecitabine
2
Adoptive Transfer
2
trastuzumab deruxtecan
1
spartalizumab
1
fludarabine
1
Tomography, X-Ray Computed
1
Surveys and Questionnaires
1
Restraint, Physical
1
Radiotherapy, Intensity-Modulated
1
Positron-Emission Tomography
1
Parturition
1
Paclitaxel
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Induction Chemotherapy
1
Immune Checkpoint Inhibitors
1
Human Papillomavirus DNA Tests
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Diagnostic Tests, Routine
1
Dehydroepiandrosterone
1
Cytological Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Anus Neoplasms
×
Immune Checkpoint Inhibitors
×
Clear all
NCT07555678
2026-04-29
Chase
Fudan University
Phase 2
Recruiting
241 enrolled